Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>Events>This Event
  Events - October 2013

Drug Discovery Re-Invented; Emerging Role of Biotechs, Academics and Non-Profits

16 Oct 2013 - 19 Oct 2013 - Scottsdale, AZ, USA

Bookmark and Share

Poster Submission Deadline: 14-Aug-13
Registration Deadline: 21-Aug-13

The conference will center on new approaches to drug discovery in an industry where the landscape is changing rapidly. With large pharma reducing investment in internal early stage research, drug pipelines will increasingly be filled by alternative sources. These players include: government, academic labs, non-profits, biotech companies, and pharmaceutical “open innovation” models. The conference will also provide examples of successful strategies for advancing new drug candidates in this era of distributed discovery.

The full programme is now available, please see conference website for details!

Key Sessions include:

  1. Discovery Re-Invented
  2. Novel Pharma Approaches
  3. Collaborative Drug Discovery
  4. Natural Products
  5. Structure, Modelling and Informatics
  6. Biologics and Non-traditional Therapeutics
  7. Discovery Technologies

This conference is designed to attract the following attendees: medicinal, computational, and synthetic organic chemists; structural and screening biologists; research management and entrepreneurs; industrial and academic scientists.

Confirmed Speakers:

Prof. William Jorgensen (Plenary), Yale University
Prof. Jef De Brabander, UT Southwestern Medical
Dr. Bart DeCorte, Janssen Research & Development
Prof. James Barrow, Johns Hopkins School of Medicine
Dr. Ken Duncan (Plenary), Bill & Melinda Gates Foundation
Dr. Guy Breitenbucher, Dart Neuroscience
Dr. Barry Bunin, Collaborative Drug Discovery
Dr. Paul Labute, Chemical Computing Group
Dr. Leah Frye, Schrodinger
Prof. Sean Brady, The Rockefeller University
Dr. Steven Young (Plenary), BeiGene
Dr. Craig Thomas, NIH Chemical Genomics Center
Dr. Michael Trzoss, Trius Therapeutics
Dr. Joseph Vacca, WuXi AppTec
Dr. Michael Goetz, Natural Products Discovery Institute
Prof. George Georgiou, The University of Texas at Austin
Dr. Benjamin Blass, Temple University School of Pharmacy
Prof. Kenneth Merz, University of Florida
Dr. Michael Foley (Plenary), Broad Institute
Dr. David Gorenstein, University of Texas HSC Houston
Dr. Zhengying Pan, Peking University, Shenzhen Graduate School
Dr. Andreas G. Bader, Mirna Therapeutics
Dr. Todd Chappell, NIH and BioHealth Innovation
Dr. Trevor Hallam, Sutro Biopharma
Dr. Patrick Lam, Lam Drug Discovery Consulting
Dr. Sandhya Kortagere, Drexel University College of Medicine
Dr. Mark McDonnell, Fox Chase Chemical Diversity Center
Dr. Serge L Boulet, Eli Lilly
Dr. Gabor Butora, Merck
Dr. Janet L. Ralbovsky, University of Tennessee Research Foundation
Dr. Paul Leeson, GlaxoSmithKline
Dr. Matthew Segall, Optibrium Ltd.
Dr. Guy Carter, Biosortia Pharmaceuticals
Dr. Chris Williams, Chemical Computing Group

Poster Submission Deadline: 14-Aug-13
Registration Deadline: 21-Aug-13

Further information
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Revolutionary Technologies Developed to Improve Outcomes for Lung Cancer Patients
Breath test to detect lung cancer brings oxygen directly to the wound.
NIH Supports New Studies to Find Alzheimer’s Biomarkers in Down Syndrome
Initiative will track dementia onset, progress in Down syndrome volunteers.
Dementia Linked to Deficient DNA Repair
Mutant forms of breast cancer factor 1 (BRCA1) are associated with breast and ovarian cancers but according to new findings, in the brain the normal BRCA1 gene product may also be linked to Alzheimer’s disease.
Using Drug-Susceptible Parasites to Fight Drug Resistance
Researchers at the University of Georgia have developed a model for evaluating a potential new strategy in the fight against drug-resistant diseases.
Boosting Breast Cancer Treatment
To more efficiently treat breast cancer, scientists have been researching molecules that selectively bind to cancer cells and deliver a substance that can kill the tumor cells, for several years.
New Gene Map Reveals Cancer’s Achilles’ Heel
Team of researchers switches off almost 18,000 genes
New Discovery Sheds Light on Disease Risk
Gaps between genes interact to influence the risk of acquiring disease.
How Cells ‘Climb’ to Build Fruit Fly Tracheas
Mipp1 protein helps cells sprout “fingers” for gripping.
Research Finding Could Lead to Targeted Therapies for IBD
Findings published online in Cell Reports.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos